Formula & Concentration

Antihemophilic Factor (Recombinant), Fc Fusion Protein

Manufacturer

Biogen Idec

Indications

“ELOCTATE Antihemophilic Factor (Recombinant), Fc Fusion Protein, is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for control and prevention of bleeding episodes, perioperative management (surgical prophylaxis), and routine prophylaxis to prevent or reduce the frequency of bleeding episodes. ELOCTATE is not indicated for the treatment of von Willebrand disease.”

Product Options

Vial Size

NDC #

250 IU

64406-801-01

500 IU

64406-802-01

750 IU

64406-803-01

1000 IU

64406-804-01

1500 IU

64406-805-01

2000 IU

64406-806-01

3000 IU

64406-807-01

Shelf Life and Storage

Store ELOCTATE in the original package to protect vials from light. Store ELOCTATE in powder form at 2°C to 8°C (36°F to 46°F). Do not freeze to avoid damage to the pre-filled diluent syringe. After reconstitution, if the product is not used within 3 hours, it must be discarded